{
    "allele": {
        "alpha": {
            "identifier": "ipd-imgt:HLA35266",
            "locus": "hla-a",
            "match_type": "histo:exact",
            "name": "HLA-A*02:01",
            "slug": "hla_a_02_01",
            "species_stem": "hla"
        },
        "beta": {}
    },
    "assemblies": {
        "1": {
            "assembly_name": "6tmo_1",
            "chains": [
                "A",
                "B",
                "C",
                "D",
                "E"
            ],
            "downloaded_at": "2022-11-09T14:29:08.120233"
        }
    },
    "assembly_count": null,
    "assigned_chains": {
        "beta2m": {
            "chains": [
                "B"
            ],
            "match_type": "histo:assign_chains",
            "score": 0.99,
            "sequence": "MIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM"
        },
        "class_i_alpha": {
            "chains": [
                "A"
            ],
            "match_type": "histo:assign_chains",
            "score": 1.0,
            "sequence": "GSHSMRYFFTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGPEYWDGETRKVKAHSQTHRVDLGTLRGYYNQSEAGSHTVQRMYGCDVGSDWRFLRGYHQYAYDGKDYIALKEDLRSWTAADMAAQTTKHKWEAAHVAEQLRAYLEGTCVEWLRRYLENGKETLQRTDAPKTHMTHHAVSDHEATLRCWALSFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGQEQRYTCHVQHEGLPKPLTLRWEP"
        },
        "peptide": {
            "chains": [
                "C"
            ],
            "match_type": "histo:classify_peptide",
            "sequence": "EAAGIGILTV"
        },
        "tcr_alpha": {
            "chains": [
                "D"
            ],
            "match_type": "stcrdab",
            "sequence": "KQEVEQNSGPLSVPEGAIASLNCTYSFLGSQSFFWYRQYSGKSPELIMFTYREGDKEDGRFTAQLNKASQHVSLLIRDSQPSDSATYLCAVNDGGRLTFGDGTTLTVKPNIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFF",
            "subgroup": "TRAV12"
        },
        "tcr_beta": {
            "chains": [
                "E"
            ],
            "match_type": "stcrdab",
            "sequence": "SQTIHQWPATLVQPVGSPLSLECTVEGTSNPNLYWYRQAAGRGPQLLFYWGPFGQISSEVPQNLSASRPQDRQFILSSKKLLLSDSGFYLCAWSETGLGMGGWQFGEGSRLTVLEDLKNVFPPEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYALSSRLRVSATFWQDPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRAD",
            "subgroup": "TRBV30"
        }
    },
    "chronology": {
        "deposition_date": "2019-12-05",
        "deposition_year": 2019,
        "release_date": "2020-10-07",
        "release_year": 2020,
        "revision_date": "2020-10-14",
        "revision_year": 2020
    },
    "class": "class_i",
    "classical": true,
    "complex_type": "class_i_with_peptide_and_alpha_beta_tcr",
    "components": [
        "class_i_alpha",
        "beta2m",
        "peptide",
        "tcr_alpha",
        "tcr_beta"
    ],
    "experimental_method": "X-ray diffraction",
    "facets": {},
    "ligands": [],
    "locus": "hla-a",
    "manually_edited": {},
    "missing_residues": [],
    "page_title": "6TMO | HLA-A*02:01 presenting \"EAAGIGILTV\" to Alpha/Beta T cell receptor",
    "pdb_code": "6tmo",
    "pdb_title": "Structure determination of an enhanced affinity TCR, a24b17, in complex with hla-a*02:01 presenting a mart-1 peptide, EAAGIGILTV",
    "peptide": {
        "C": {
            "actual_length": 10,
            "actual_sequence": "EAAGIGILTV",
            "chain_id": "C",
            "features": [
                "correct_sequence_and_length"
            ],
            "full_length": 10,
            "full_sequence": "EAAGIGILTV"
        }
    },
    "peptide_length": 10,
    "peptide_length_name": "decamer",
    "peptide_sequence": "EAAGIGILTV",
    "publication": {
        "abstract": "Immuno-oncology approaches that utilize T\u00a0cell receptors (TCRs) are becoming highly attractive because of their potential to target virtually all cellular proteins, including cancer-specific epitopes, via the recognition of peptide-human leukocyte antigen (pHLA) complexes presented at the cell surface. However, because natural TCRs generally recognize cancer-derived pHLAs with very weak affinities, efforts have been made to enhance their binding strength, in some cases by several million-fold. In this study, we investigated the mechanisms underpinning human TCR affinity enhancement by comparing the crystal structures of engineered enhanced affinity TCRs with those of their wild-type progenitors. Additionally, we performed molecular dynamics simulations to better understand the energetic mechanisms driving the affinity enhancements. These data demonstrate that supra-physiological binding affinities can be achieved without altering native TCR-pHLA binding modes via relatively subtle modifications to the interface contacts, often driven through the addition of\u00a0buried hydrophobic residues. Individual energetic components of the TCR-pHLA interaction governing affinity enhancements were distinct and highly variable for each TCR, often resulting from additive, or knock-on, effects beyond the mutated residues. This comprehensive analysis of affinity-enhanced TCRs has important implications for the future rational design of engineered TCRs as efficacious and safe drugs for cancer treatment.",
        "bibjson": {
            "author": [
                {
                    "initials": "RM",
                    "lastname": "Crean",
                    "name": "Crean RM"
                },
                {
                    "initials": "BJ",
                    "lastname": "MacLachlan",
                    "name": "MacLachlan BJ"
                },
                {
                    "initials": "F",
                    "lastname": "Madura",
                    "name": "Madura F"
                },
                {
                    "initials": "T",
                    "lastname": "Whalley",
                    "name": "Whalley T"
                },
                {
                    "initials": "PJ",
                    "lastname": "Rizkallah",
                    "name": "Rizkallah PJ"
                },
                {
                    "initials": "CJ",
                    "lastname": "Holland",
                    "name": "Holland CJ"
                },
                {
                    "initials": "C",
                    "lastname": "McMurran",
                    "name": "McMurran C"
                },
                {
                    "initials": "S",
                    "lastname": "Harper",
                    "name": "Harper S"
                },
                {
                    "initials": "A",
                    "lastname": "Godkin",
                    "name": "Godkin A"
                },
                {
                    "initials": "AK",
                    "lastname": "Sewell",
                    "name": "Sewell AK"
                },
                {
                    "initials": "CR",
                    "lastname": "Pudney",
                    "name": "Pudney CR"
                },
                {
                    "initials": "MW",
                    "lastname": "van der Kamp",
                    "name": "van der Kamp MW"
                },
                {
                    "initials": "DK",
                    "lastname": "Cole",
                    "name": "Cole DK"
                }
            ],
            "identifier": [
                {
                    "id": "10.1016/j.omto.2020.07.008",
                    "type": "doi"
                },
                {
                    "id": "32913893",
                    "type": "pubmed"
                }
            ],
            "issue": [
                null
            ],
            "journal": {
                "iso_abbreviation": null,
                "name": ""
            },
            "pages": [
                "443-456"
            ],
            "title": "Molecular Rules Underpinning Enhanced Affinity Binding of Human T Cell Receptors Engineered for Immunotherapy.",
            "type": "article",
            "url": "https://www.sciencedirect.com/science/article/abs/pii/S2372770520301121",
            "volume": [
                null
            ],
            "year": [
                2020
            ]
        },
        "in_pmc": "N",
        "in_pmce": "Y",
        "open_access": "Y"
    },
    "resolution": "2.10",
    "same_as": {
        "pdbe": {
            "url": "https://www.ebi.ac.uk/pdbe/entry/pdb/6tmo"
        },
        "rcsb": {
            "url": "https://www.rcsb.org/structure/6tmo"
        },
        "stcrdab": {
            "url": "http://opig.stats.ox.ac.uk/webapps/stcrdab/StrViewer?pdb=6tmo"
        }
    },
    "species": {
        "common_name": "Human",
        "match_type": "histo:assign_species",
        "scientific_name": "Homo sapiens",
        "slug": "homo_sapiens"
    },
    "tcr": {
        "alpha": {
            "chains": [
                "D"
            ],
            "subgroup": "TRAV12"
        },
        "beta": {
            "chains": [
                "E"
            ],
            "subgroup": "TRBV30"
        },
        "mhc_type": "class_i",
        "pdb_code": "6tmo"
    },
    "title": "HLA-A*02:01 presenting \"EAAGIGILTV\" to Alpha/Beta T cell receptor at 2.10&#8491; resolution",
    "unique_chain_count": 5
}